Evidence map›Paper›PMID 38002967›Full record

ArticleGenes2023

Navigating the ALS Genetic Labyrinth: The Role of MAPT Haplotypes.

Ivan Tourtourikov, Kristiyan Dabchev, Tihomir Todorov, Teodor Angelov, Teodora Chamova, Ivailo Tournev, Tanya Kadiyska, Vanyo Mitev, Albena Todorova

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ivan TourtourikovDepartment of Medical Chemistry and Biochemistry, Medical University of Sofia, 1431 Sofia, Bulgaria.ORCID 0000-0003-3094-8030
Kristiyan DabchevGenetic Medico Diagnostic Laboratory Genica, 1612 Sofia, Bulgaria.
Tihomir TodorovGenetic Medico Diagnostic Laboratory Genica, 1612 Sofia, Bulgaria.
Teodor AngelovDepartment of Neurology, Faculty of Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria.
Teodora ChamovaDepartment of Neurology, Faculty of Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria.
Ivailo TournevDepartment of Neurology, Clinic of Nervous Diseases, Medical University of Sofia, UMBAL Aleksandrovska, 1431 Sofia, Bulgaria.ORCID 0000-0002-2399-9297
Tanya KadiyskaGenetic Medico Diagnostic Laboratory Genica, 1612 Sofia, Bulgaria.
Vanyo MitevDepartment of Medical Chemistry and Biochemistry, Medical University of Sofia, 1431 Sofia, Bulgaria.
Albena TodorovaDepartment of Medical Chemistry and Biochemistry, Medical University of Sofia, 1431 Sofia, Bulgaria.
Medical University of Sofia · BGAgrobioinstitute · BGNew Bulgarian University · BG

Funding

Medical University Sofia D-186/ 14.06.2022
6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by wide clinical and biological heterogeneity, with a large proportion of ALS patients also exhibiting frontotemporal dementia (FTD) spectrum symptoms. This project aimed to characterize risk subtypes of the H1 haplotype within the

Indexed as

Amyotrophic Lateral SclerosisNeurodegenerative DiseasesGenetic Predisposition to DiseaseHaplotypesHumanstau ProteinsMAPT protein, humantau ProteinsALSH1 haplotypeMAPTneurodegenerative disorders

Identifiers

PMID38002967
PMCPMC10671552
OpenAlexW4388019630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.